484
Views
4
CrossRef citations to date
0
Altmetric
Original

PEG-conjugated Hemoglobin Combination with Cisplatin Enforced the Antiangiogeic Effect in a Cervical Tumor Xenograft Model

, , , , , & show all
Pages 487-497 | Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Bingting Li, Jun Zhang, Ning Ma, Weidan Li, Guoxing You, Gan Chen, Lian Zhao, Quan Wang & Hong Zhou. (2023) PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 51:1, pages 120-130.
Read now
Jianqun Han, Minhua Yu, Min Dai, Hongwei Li, Ruijuan Xiu & Qian Liu. (2012) Decreased expression of MDR1 in PEG-conjugated hemoglobin solution combined cisplatin treatment in a tumor xenograft model. Artificial Cells, Blood Substitutes, and Biotechnology 40:4, pages 239-244.
Read now

Articles from other publishers (2)

Yun Sun, Zhiguo Zhou, Shiping Yang & Hong Yang. (2021) Modulating hypoxia inducible factor‐1 by nanomaterials for effective cancer therapy. WIREs Nanomedicine and Nanobiotechnology 14:1.
Crossref
Nikki P. Lee, Kin Tak Chan, Mei Yuk Choi, Ho Yu Lam, Lai Nar Tung, Fei Chuen Tzang, Heron Han, Ian P. Y. Lam, Sui Yi Kwok, Sze Hang Lau, Cornelia Man, Daniel K. Tong, Bing L. Wong & Simon Law. (2015) Oxygen carrier YQ23 can enhance the chemotherapeutic drug responses of chemoresistant esophageal tumor xenografts. Cancer Chemotherapy and Pharmacology 76:6, pages 1199-1207.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.